Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is linked genetically to proteins that function in the management of cellular stress resulting from protein misfolding and oxidative damage. Overexpression or mutation of α-synuclein results in the formation of Lewy bodies and neurodegeneration of dopaminergic (DA) neurons. Human torsinA, mutations in which cause another movement disorder termed early-onset torsion dystonia, is highly expressed in DA neurons and is also a component of Lewy bodies. Previous work has established torsins as having molecular chaperone activity. Thus, we examined the ability of torsinA to manage cellular stress within DA neurons of the nematode Caenorhabditis elegans.Worm DA neurons undergo a reproducible pattern of neurodegeneration after treatment with 6-hydroxydopamine (6-OHDA), a neurotoxin commonly used to model PD. Overexpression of torsins in C. elegans DA neurons results in dramatic suppression of neurodegeneration after 6-OHDA treatment. In contrast, expression of either dystonia-associated mutant torsinA or combined overexpression of wild-type and mutant torsinA yielded greatly diminished neuroprotection against 6-OHDA. We further demonstrated that torsins seem to protect DA neurons from 6-OHDA through downregulating protein levels of the dopamine transporter (DAT-1)in vivo. Additionally, we determined that torsins protect robustly against DA neurodegeneration caused by overexpression of α-synuclein. Using mutant nematodes lacking DAT-1 function, we also showed that torsin neuroprotection from α-synuclein-induced degeneration occurs in a manner independent of this transporter. Together, these data have mechanistic implications for movement disorders, because our results demonstrate that torsin proteins have the capacity to manage sources of cellular stress within DA neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE GENETICS OF CAENORHABDITIS ELEGANS
Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,081
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“…and sporadic PD. Central to the formation of Lewy bodies is ␣-synuclein, a polypeptide with a propensity toward intracellular aggregation when mutated or present in multiple wild-type copies (Polymeropoulos et al., 1997; Conway et al., 2000, 2001; Singleton et al., 2003; Farrer et al., 2004).”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · cited 3×
“Because multiple copies of the ␣-synuclein gene are sufficient to cause PD without additional mutations (Singleton et al., 2003; Farrer et al., 2004), we set out to determine whether the higher percentage of worms exhibiting neuroprotection in torsin-overexpressing lines was attributable to a…”
BackgroundC. elegans: des neurones et des gènes
Gally, C., & Bessereau, J.-L. (2003) · médecine/sciences · doi:10.1051/medsci/20031967725 · Cited by 3,287
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Neuwald, A. F., Aravind, L., Spouge, J. L., & Koonin, E. V. (1999) · Genome Research · doi:10.1101/gr.9.1.27 · Cited by 1,828
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · cited 1×
“Auluck et al. (2002) demonstrated that Hsp70 is able to suppress ␣-synuclein-induced neurotoxicity without changing the number, morphology, or distribution of the perinuclear protein inclusions in Drosophila, indicating that protofibrils, not the mature fibrils or aggregates, represent the…”
BackgroundKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
Ozelius, L. J., Hewett, J. W., Page, C. E., Bressman, S. B., Kramer, P. L., Shalish, C., de Leon, D., Brin, M. F., Raymond, D., Corey, D. P., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-40 · Cited by 1,007
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Xu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
Lewis, J. A., & Fleming, J. T. (1995) · PubMed · Cited by 637
Hobert, O. (2002) · BioTechniques · doi:10.2144/02324bm01 · Cited by 624
Environmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
(2004) · doi:10.1002/ana.10846 · Cited by 614
A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 2×
“How do torsins protect DA neurons against various cellular insults? DA metabolism is believed to play a role in the selective toxicity of -synuclein within neurons, because numerous lines of evidence have suggested that -synuclein participates in regulating DA biosynthesis, vesicular storage, release, and reuptake (Sh…”
BackgroundJenner, P., Dexter, D. T., Sian, J., Schapira, A. H. V., Marsden, C. D., & The Royal Kings And Queens Parkinson's Disease Research Group (1992) · Annals of Neurology · doi:10.1002/ana.410320714 · Cited by 544
Dopaminergic neurons in the nematode Caenorhabditis elegans
Sulston, J., Dew, M., & Brenner, S. (1975) · Journal of Comparative Neurology · doi:10.1002/cne.901630207 · Cited by 476
Chapter 1 Basic Culture Methods
Lewis, J. A., & Fleming, J. T. (1995) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61381-3 · Cited by 471
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans
Nass, R., Hall, D. H., Miller, D. M., & Blakely, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042497999 · Cited by 417
Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
Satyal, S. H., Schmidt, E., Kitagawa, K., Sondheimer, N., Lindquist, S., Kramer, J. M., & Morimoto, R. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100107297 · Cited by 371
(2003) · doi:10.1046/j.1471-4159.2003.01809.x · Cited by 349
The role of α-synuclein in Parkinson's disease: insights from animal models
Maries, E., Dass, B., Collier, T. J., Kordower, J. H., & Steece-Collier, K. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1199 · Cited by 344
Sharon, R., Goldberg, M. S., Bar-Josef, I., Betensky, R. A., Shen, J., & Selkoe, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171300598 · Cited by 328
HSP27 Is a Ubiquitin-Binding Protein Involved in I-κBα Proteasomal Degradation
Parcellier, A., Schmitt, E., Gurbuxani, S., Seigneurin-Berny, D., Pance, A., Chantôme, A., Plenchette, S., Khochbin, S., Solary, E., & Garrido, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5790-5802.2003 · Cited by 325
TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation
McLean, P. J., Kawamata, H., Shariff, S., Hewett, J., Sharma, N., Ueda, K., Breakefield, X. O., & Hyman, B. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01190.x · Cited by 324
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313 · cited 1×
“The specific metabolism of dopamine in neurons also contributes to additional vulnerability from cellular stress and degeneration (Fahn and Cohen, 1992; Jellinger et al., 1992; Jenner et al., 1992).”
BackgroundDuerr, J. S., Frisby, D. L., Gaskin, J., Duke, A., Asermely, K., Huddleston, D., Eiden, L. E., & Rand, J. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00072.1999 · Cited by 282
Mislocalization to the nuclear envelope: An effect of the dystonia-causing torsinA mutation
Goodchild, R. E., & Dauer, W. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304375101 · Cited by 258
Genes necessary for directed axonal elongation or fasciculation in C. elegans
McIntire, S. L., Garriga, G., White, J., Jacobson, D., & Robert Horvitz, H. (1992) · Neuron · doi:10.1016/0896-6273(92)90297-q · Cited by 247
Variability and validity of polymorphism association studies in Parkinson’s disease
Tan, E. K., Khajavi, M., Thornby, J. I., Nagamitsu, S., Jankovic, J., & Ashizawa, T. (2000) · Neurology · doi:10.1212/wnl.55.4.533 · Cited by 219
Hobert, O., Moerman, D. G., Clark, K. A., Beckerle, M. C., & Ruvkun, G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.1.45 · Cited by 206
Lints, R., & Emmons, S. W. (1999) · Development · doi:10.1242/dev.126.24.5819 · Cited by 206
Free Radical‐Generated Neurotoxicity of 6‐Hydroxydopamine
Kumar, R., Agarwal, A. K., & Seth, P. K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041703.x · Cited by 202
Hewett, J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1403 · Cited by 201
Herkenham, M., Little, M. D., Bankiewicz, K., Yang, S.-C., Markey, S. P., & Johannessen, J. N. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90180-v · Cited by 180
Torres, G. E., Sweeney, A. L., Beaulieu, J.-M., Shashidharan, P., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308088101 · Cited by 175
Striatal dopamine transporter density in major depression
Laasonen-Balk, T., Kuikka, J., Viinam�ki, H., Husso-Saastamoinen, M., Lehtonen, J., & Tiihonen, J. (1999) · Psychopharmacology · doi:10.1007/s002130051005 · Cited by 172
Sidhu, A., Wersinger, C., & Vernier, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.063 · Cited by 170
Kustedjo, K., Bracey, M. H., & Cravatt, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910025199 · Cited by 170
Berger, K., Przedborski, S., & Cadet, J. L. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90242-c · Cited by 153
Gonzalez‐Alegre, P., & Paulson, H. L. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4461-03.2004 · Cited by 151
Wersinger, C., Prou, D., Vernier, P., & Sidhu, A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0152fje · Cited by 144
Animal Models of Movement Disorders
(2011) · Neuromethods · doi:10.1007/978-1-61779-301-1 · Cited by 140
Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson’s disease
Foley, P., & Riederer, P. F. (2000) · Journal of Neurology · doi:10.1007/pl00007766 · Cited by 138
Caldwell, G. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.307 · Cited by 132
Self-citationDopamine transmission in DYT1 dystonia: A biochemical and autoradiographical study
Augood, S. J., Hollingsworth, Z. R., Albers, D. S., Yang, L., Leung, J., Müller, B., Klein, C., Breakefield, X. O., & Standaert, D. G. (2002) · Neurology · doi:10.1212/wnl.59.3.445 · Cited by 122
A Close Association of TorsinA and α-Synuclein in Lewy Bodies
Sharma, N., Hewett, J. W., Ozelius, L. J., Ramesh, V., McLean, P. J., Breakefield, X. O., & Hyman, B. T. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61700-2 · Cited by 120
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers
Heiman, G. A., Ottman, R., Saunders-Pullman, R. J., Ozelius, L. J., Risch, N. J., & Bressman, S. B. (2004) · Neurology · doi:10.1212/01.wnl.0000137113.39225.fa · Cited by 119
TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease
Shashidharan, P., Good, P. F., Hsu, A., Perl, D. P., Brin, M. F., & Olanow, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02702-5 · Cited by 107
Brunswick, D. J., Amsterdam, J. D., Mozley, P. D., & Newberg, A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1836 · Cited by 104
Developmental expression of rat torsinA transcript and protein
Xiao, J., Gong, S., Zhao, Y., & LeDoux, M. S. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.05.012 · Cited by 64
Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain
Walker, R. H., Brin, M. F., Sandu, D., Gujjari, P., Hof, P. R., Olanow, C. W., & Shashidharan, P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02302-2 · Cited by 47
Overexpression of torsinA in PC12 cells protects against toxicity
Shashidharan, P., Paris, N., Sandu, D., Karthikeyan, L., McNaught, K. S. P., Walker, R. H., & Olanow, C. W. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02233.x · Cited by 45
Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector.
Ginns, E. I., Rehavi, M., Martin, B. M., Weller, M., O’Malley, K. L., LaMarca, M. E., McAllister, C. G., & Paul, S. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68656-9 · Cited by 31
Helfand, S. L. (2002) · Science · doi:10.1126/science.1069544 · Cited by 25
Use of C. elegans to Model Human Movement Disorders
Caldwell, G. A., Cao, S., Izevbaye, I., & Caldwell, K. A. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50009-8 · Cited by 2
Self-citation
Cited by
α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F., et al. (2006) · Science · doi:10.1126/science.1129462 · Cited by 1,376
Self-citationCaenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology
Leung, M. C. K., Williams, P. L., Benedetto, A., Au, C., Helmcke, K. J., Aschner, M., & Meyer, J. N. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn121 · Cited by 1,027
α-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J.-C., et al. (2009) · Nature Genetics · doi:10.1038/ng.300 · Cited by 535
Self-citationThe pathophysiological basis of dystonias
Breakefield, X. O., Blood, A. J., Li, Y., Hallett, M., Hanson, P. I., & Standaert, D. G. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2337 · Cited by 448
Metadata
- Authors
- Cao, S., Gelwix, C. C., Caldwell, K. A., & Caldwell, G. A.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2005-04-13
- Volume
- 25
- Issue
- 15
- Pages
- 3801-3812
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2055956984
- Cited by
- 271
- References
- 65
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.